Kewaunee Scientific Corporation(KEQU)Earnings, Financials & Key Ratios
KEQU•NASDAQ
$37.00
$106M mkt cap·9.7× P/E·Price updated May 6, 2026
AboutKewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.Show more
- Revenue$240M+18.0%
- EBITDA$23M+5.2%
- Net Income$11M-39.2%
- EPS (Diluted)3.83-40.0%
- Gross Margin28.63%+12.1%
- EBITDA Margin9.36%-10.9%
- Operating Margin7.39%-17.7%
- Net Margin4.74%-48.5%
- ROE18.63%-53.0%
- ROIC18.32%-41.7%
- Debt/Equity0.76+286.8%
- Interest Coverage5.53-45.6%
KEQU Key Insights
Kewaunee Scientific Corporation (KEQU) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 20.6%
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 10.3%
- ✓Efficient asset utilization: 1.2x turnover
✗Weaknesses
- ✗Thin 5Y average net margin of 1.7%
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
KEQU Price & Volume
Kewaunee Scientific Corporation (KEQU) stock price & volume — 10-year historical chart
Loading chart...
KEQU Growth Metrics
Kewaunee Scientific Corporation (KEQU) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years7.3%
5 Years10.26%
3 Years12.5%
TTM30.78%
Profit CAGR
10 Years12.45%
5 Years-
3 Years-
TTM-36.98%
EPS CAGR
10 Years11.16%
5 Years-
3 Years-
TTM-37.06%
Return on Capital
10 Years7.46%
5 Years6.93%
3 Years13.65%
Last Year15.12%
KEQU Recent Earnings
Kewaunee Scientific Corporation (KEQU) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
Mar 11, 2026EPS
$0.28
Revenue
$69M
Q4 2025
Dec 10, 2025EPS
$0.91
Revenue
$70M
Q4 2025
Sep 10, 2025EPS
$1.10
Revenue
$71M
Q3 2025
Jun 25, 2025EPS
$1.95
Revenue
$77M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 11, 2026 | $0.28 | $69M |
| Q4 2025 | Dec 10, 2025 | $0.91 | $70M |
| Q4 2025 | Sep 10, 2025 | $1.10 | $71M |
| Q3 2025 | Jun 25, 2025 | $1.95 | $77M |
Based on last 12 quarters of dataView full earnings history →
KEQU Peer Comparison
Kewaunee Scientific Corporation (KEQU) competitors in Commercial and Institutional Furnishings — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LCUT | 126.18M | 5.57 | -4.49 | -5.13% | -4.16% | -13.5% | 0.31 | |
 VIRC | 95.67M | 6.07 | 4.60 | -1.07% | 5.74% | 11.78% | 0.38 | |
 FLXS | 293.98M | 54.99 | 15.49 | 6.86% | 4.75% | 12.17% | 0.35 | |
 HOFT | 134.59M | 12.52 | -10.43 | -8.25% | -3.4% | -6.62% | 0.34 | |
 HNI | 1.63B | 33.29 | 29.99 | 12.37% | -0.43% | -1.17% | 0.89 | |
 SCS | 1.85B | 16.14 | 15.82 | 0.2% | 2.92% | 9.38% | 0.63 | |
 UFI | 72.09M | 3.88 | -3.50 | -1.87% | -7.16% | -16.7% | 0.46 | |
 ACCO | 371.8M | 4.03 | 9.16 | -8.49% | 4.76% | 11.26% | 1.39 |
Compare KEQU vs Peers
Kewaunee Scientific Corporation (KEQU) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
KEQU Income Statement
Kewaunee Scientific Corporation (KEQU) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Apr'17 | Apr'18 | Apr'19 | Apr'20 | Apr'21 | Apr'22 | Apr'23 | Apr'24 | Apr'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 138.56M | 158.05M | 146.55M | 147.54M | 147.47M | 168.87M | 219.49M | 203.75M | 240.47M | 287.75M |
| Revenue Growth % | 7.72% | 14.07% | -7.28% | 0.68% | -0.05% | 14.51% | 29.98% | -7.17% | 18.02% | 30.78% |
| Cost of Goods Sold | 111.95M | 126.03M | 121.23M | 124.11M | 123.48M | 144.65M | 183.91M | 151.7M | 171.62M | 204.51M |
| COGS % of Revenue | 80.8% | 79.74% | 82.72% | 84.12% | 83.73% | 85.66% | 83.79% | 74.45% | 71.37% | - |
| Gross Profit | 26.61M▲ 0% | 32.02M▲ 20.3% | 25.32M▼ 20.9% | 23.43M▼ 7.5% | 23.99M▲ 2.4% | 24.22M▲ 0.9% | 35.59M▲ 46.9% | 52.05M▲ 46.3% | 68.86M▲ 32.3% | 83.23M▲ 0% |
| Gross Margin % | 19.2% | 20.26% | 17.28% | 15.88% | 16.27% | 14.34% | 16.21% | 25.55% | 28.63% | 28.93% |
| Gross Profit Growth % | 12.23% | 20.34% | -20.93% | -7.47% | 2.42% | 0.95% | 46.94% | 46.26% | 32.29% | - |
| Operating Expenses | 20.07M | 22.93M | 23.21M | 25.77M | 25.31M | 26.83M | 30.22M | 33.77M | 51.1M | 63.23M |
| OpEx % of Revenue | 14.48% | 14.51% | 15.84% | 17.47% | 17.16% | 15.89% | 13.77% | 16.57% | 21.25% | - |
| Selling, General & Admin | 20.07M | 22.24M | 23.21M | 26.23M | 26.46M | 26.8M | 29.93M | 37.95M | 51.1M | 15.54M |
| SG&A % of Revenue | 14.48% | 14.07% | 15.84% | 17.78% | 17.94% | 15.87% | 13.64% | 18.62% | 21.25% | - |
| Research & Development | 1.16M | 1.54M | 1.55M | 1.82M | 1.41M | 990K | 1.01M | 920K | 0 | 919K |
| R&D % of Revenue | 0.84% | 0.97% | 1.06% | 1.23% | 0.95% | 0.59% | 0.46% | 0.45% | - | - |
| Other Operating Expenses | 496K | 693K | 389K | 25.32M | 24.16M | 26.83M | 30.22M | -5.1M | 0 | 2.08M |
| Operating Income | 6.54M▲ 0% | 9.09M▲ 38.9% | 2.11M▼ 76.8% | -2.35M▼ 211.0% | -1.32M▲ 43.9% | -2.61M▼ 98.2% | 3.63M▲ 239.3% | 18.28M▲ 403.3% | 17.76M▼ 2.9% | 20M▲ 0% |
| Operating Margin % | 4.72% | 5.75% | 1.44% | -1.59% | -0.89% | -1.54% | 1.65% | 8.97% | 7.39% | 6.95% |
| Operating Income Growth % | 14.81% | 38.89% | -76.76% | -211.03% | 43.88% | -98.18% | 239.26% | 403.33% | -2.86% | - |
| EBITDA | 9.24M | 11.85M | 4.68M | 309K | 1.37M | 161K | 6.5M | 21.41M | 22.52M | 26.3M |
| EBITDA Margin % | 6.67% | 7.5% | 3.2% | 0.21% | 0.93% | 0.1% | 2.96% | 10.51% | 9.36% | 9.14% |
| EBITDA Growth % | 11.51% | 28.16% | -60.47% | -93.4% | 343.69% | -88.26% | 3936.65% | 229.37% | 5.19% | 39.74% |
| D&A (Non-Cash Add-back) | 2.7M | 2.76M | 2.57M | 2.65M | 2.69M | 2.77M | 2.87M | 3.13M | 4.76M | 6.3M |
| EBIT | 6.54M | 9.22M | 1.82M | -2.37M | -2.23M | -1.85M | 5.29M | 14.92M | 18M | 20.39M |
| Net Interest Income | -292K | -299K | -367K | -493K | -389K | -632K | -1.73M | -1.8M | -3.21M | -4.39M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 292K | 299K | 367K | 493K | 389K | 632K | 1.73M | 1.8M | 3.21M | 4.39M |
| Other Income/Expense | 204K | -300K | 22K | -521K | -1.3M | 123K | -866K | -5.16M | -2.97M | -3.87M |
| Pretax Income | 6.75M▲ 0% | 9.48M▲ 40.5% | 2.13M▼ 77.5% | -2.87M▼ 234.3% | -2.62M▲ 8.7% | -2.48M▲ 5.0% | 4.5M▲ 281.0% | 13.12M▲ 191.7% | 14.79M▲ 12.7% | 16.13M▲ 0% |
| Pretax Margin % | 4.87% | 6% | 1.46% | -1.94% | -1.77% | -1.47% | 2.05% | 6.44% | 6.15% | 5.6% |
| Income Tax | 2.13M | 4.12M | 446K | 1.76M | 990K | 3.52M | 3.14M | -5.94M | 3.2M | 4.41M |
| Effective Tax Rate % | 31.51% | 43.41% | 20.9% | -61.34% | -37.83% | -141.57% | 69.79% | -45.26% | 21.66% | 27.32% |
| Net Income | 4.51M▲ 0% | 5.19M▲ 14.9% | 1.53M▼ 70.5% | -4.62M▼ 402.4% | -3.61M▲ 22.0% | -6M▼ 66.4% | 1.36M▲ 122.6% | 18.75M▲ 1279.9% | 11.4M▼ 39.2% | 11.08M▲ 0% |
| Net Margin % | 3.26% | 3.28% | 1.04% | -3.13% | -2.45% | -3.55% | 0.62% | 9.2% | 4.74% | 3.85% |
| Net Income Growth % | 18.75% | 14.91% | -70.53% | -402.42% | 21.99% | -66.43% | 122.64% | 1279.91% | -39.18% | -36.98% |
| Net Income (Continuing) | 4.62M | 5.46M | 1.69M | -4.62M | -3.61M | -6M | 1.36M | 19.06M | 11.58M | 11.72M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 374K | 462K | 603K | 288K | 246K | 486K | 1.08M | 1.45M | 1.79M | 1.85M |
| EPS (Diluted) | 1.66▲ 0% | 1.87▲ 12.7% | 0.55▼ 70.6% | -1.68▼ 405.5% | -1.31▲ 22.0% | -2.15▼ 64.1% | 0.47▲ 121.9% | 6.38▲ 1257.4% | 3.83▼ 40.0% | 3.71▲ 0% |
| EPS Growth % | 16.9% | 12.65% | -70.59% | -405.45% | 22.02% | -64.12% | 121.86% | 1257.45% | -39.97% | -37.06% |
| EPS (Basic) | 1.67 | 1.91 | 0.56 | -1.68 | -1.31 | -2.15 | 0.48 | 6.51 | 3.98 | - |
| Diluted Shares Outstanding | 2.73M | 2.78M | 2.79M | 2.75M | 2.76M | 2.79M | 2.9M | 2.94M | 2.98M | 2.98M |
| Basic Shares Outstanding | 2.71M | 2.72M | 2.74M | 2.75M | 2.76M | 2.79M | 2.82M | 2.88M | 2.86M | 2.87M |
| Dividend Payout Ratio | 34.77% | 34.58% | 132.77% | - | - | - | - | - | - | - |
KEQU Balance Sheet
Kewaunee Scientific Corporation (KEQU) balance sheet — assets, liabilities & shareholders' equity
| Line item | Apr'17 | Apr'18 | Apr'19 | Apr'20 | Apr'21 | Apr'22 | Apr'23 | Apr'24 | Apr'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 59.81M | 63.5M | 65.36M | 54.23M | 60.46M | 91.56M | 87.92M | 96.82M | 118.36M | 103.58M |
| Cash & Short-Term Investments | 12.51M | 9.72M | 10.65M | 4.37M | 5.21M | 4.43M | 8.08M | 23.27M | 14.94M | 10.35M |
| Cash Only | 12.51M | 9.72M | 10.65M | 4.37M | 5.21M | 4.43M | 8.08M | 23.27M | 14.94M | 10.35M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 29.89M | 32.66M | 33.26M | 28.06M | 32.88M | 54.71M | 46.08M | 45.06M | 62.38M | 54.13M |
| Days Sales Outstanding | 78.74 | 75.42 | 82.84 | 69.42 | 81.39 | 118.25 | 76.63 | 80.73 | 94.69 | 73.71 |
| Inventory | 14.94M | 17.66M | 17.21M | 15.33M | 16.52M | 23.8M | 21.89M | 20.68M | 32.85M | 32.91M |
| Days Inventory Outstanding | 48.69 | 51.15 | 51.8 | 45.08 | 48.82 | 60.04 | 43.44 | 49.75 | 69.86 | 60.76 |
| Other Current Assets | 1.44M | 1.24M | 509K | 3.57M | 1.48M | 2.46M | 11.87M | 4.82M | 8.19M | 6.19M |
| Total Non-Current Assets | 20.59M | 20.85M | 21.87M | 29.7M | 28.93M | 27.21M | 30.98M | 37.95M | 76.29M | 72.38M |
| Property, Plant & Equipment | 14.03M | 14.66M | 16.46M | 25.58M | 25.26M | 22.69M | 25.57M | 25.1M | 36.14M | 33.06M |
| Fixed Asset Turnover | 9.88x | 10.78x | 8.90x | 5.77x | 5.84x | 7.44x | 8.58x | 8.12x | 6.65x | 8.30x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.49M | 12.49M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.83M | 16.68M |
| Long-Term Investments | 0 | 4.05M | 3.06M | 2.48M | 1.3M | 1.22M | 1.1M | 0 | 1.86M | 6.69M |
| Other Non-Current Assets | 3.4M | 4.16M | 3.58M | 3.78M | 2.37M | 4.09M | 4.46M | 5.45M | 3.98M | 20.57M |
| Total Assets | 80.4M▲ 0% | 84.36M▲ 4.9% | 87.22M▲ 3.4% | 83.93M▼ 3.8% | 89.38M▲ 6.5% | 118.77M▲ 32.9% | 118.9M▲ 0.1% | 134.77M▲ 13.3% | 194.65M▲ 44.4% | 175.96M▲ 0% |
| Asset Turnover | 1.72x | 1.87x | 1.68x | 1.76x | 1.65x | 1.42x | 1.85x | 1.51x | 1.24x | 1.53x |
| Asset Growth % | 11.04% | 4.93% | 3.4% | -3.78% | 6.5% | 32.88% | 0.11% | 13.35% | 44.44% | 124.63% |
| Total Current Liabilities | 26.93M | 27.56M | 32.73M | 27.06M | 34.18M | 42.29M | 40.05M | 40.78M | 53.71M | 48.78M |
| Accounts Payable | 11.99M | 14.75M | 15.19M | 13.11M | 16.78M | 27.32M | 23.6M | 23.26M | 27.03M | 23.64M |
| Days Payables Outstanding | 39.11 | 42.73 | 45.73 | 38.57 | 49.6 | 68.93 | 46.84 | 55.97 | 57.5 | 44.47 |
| Short-Term Debt | 4.51M | 5.05M | 10.68M | 4.72M | 6.83M | 2.16M | 3.59M | 3.1M | 3.89M | 10.53M |
| Deferred Revenue (Current) | 5.81M | 1.88M | 1.6M | 2.51M | 3.12M | 3.53M | 4.1M | 4.37M | 6.07M | 10.14M |
| Other Current Liabilities | 1.85M | 2.12M | 3.74M | 1.26M | 1.35M | 3.34M | 4.95M | 6.75M | 10M | 10.55M |
| Current Ratio | 2.22x | 2.30x | 2.00x | 2.00x | 1.77x | 2.17x | 2.20x | 2.37x | 2.20x | 2.20x |
| Quick Ratio | 1.67x | 1.66x | 1.47x | 1.44x | 1.29x | 1.60x | 1.65x | 1.87x | 1.59x | 1.59x |
| Cash Conversion Cycle | 88.32 | 83.85 | 88.91 | 75.94 | 80.61 | 109.37 | 73.23 | 74.51 | 107.06 | 90 |
| Total Non-Current Liabilities | 9.33M | 9.28M | 6.79M | 18.17M | 13.72M | 40.3M | 40.36M | 37.78M | 74.7M | 54.65M |
| Long-Term Debt | 2.43M | 1.26M | 97K | 0 | 0 | 28.77M | 28.13M | 0 | 33.95M | 22.82M |
| Capital Lease Obligations | 0 | 0 | 132K | 7.89M | 7.95M | 35.18M | 35.42M | 5.67M | 8.95M | 50.9M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 401K | 307K | 428K | 943K | 1.22M | 1.1M | 4.38M |
| Other Non-Current Liabilities | 8.3M | 8.01M | 6.56M | 9.87M | 5.46M | -24.09M | -24.13M | 30.89M | 30.7M | 121.65M |
| Total Liabilities | 36.26M | 36.84M | 39.52M | 45.23M | 47.9M | 82.59M | 80.41M | 78.56M | 128.41M | 103.43M |
| Total Debt | 4.51M | 5.05M | 10.93M | 13.8M | 16.15M | 67.56M | 12.92M | 11M | 50.16M | 59.34M |
| Net Debt | -8M | -4.66M | 279K | 9.44M | 10.94M | 63.13M | 4.84M | -12.27M | 35.21M | 48.99M |
| Debt / Equity | 0.10x | 0.11x | 0.23x | 0.36x | 0.39x | 1.87x | 0.34x | 0.20x | 0.76x | 0.76x |
| Debt / EBITDA | 0.49x | 0.43x | 2.33x | 44.66x | 11.78x | 419.66x | 1.99x | 0.51x | 2.23x | 2.26x |
| Net Debt / EBITDA | -0.87x | -0.39x | 0.06x | 30.53x | 7.98x | 392.12x | 0.75x | -0.57x | 1.56x | 1.56x |
| Interest Coverage | 22.40x | 30.39x | 5.75x | -4.76x | -3.38x | -4.13x | 2.09x | 10.16x | 5.53x | 4.64x |
| Total Equity | 44.14M▲ 0% | 47.52M▲ 7.7% | 47.7M▲ 0.4% | 38.7M▼ 18.9% | 41.49M▲ 7.2% | 36.18M▼ 12.8% | 38.48M▲ 6.4% | 56.21M▲ 46.1% | 66.25M▲ 17.9% | 72.53M▲ 0% |
| Equity Growth % | 14.49% | 7.67% | 0.38% | -18.87% | 7.19% | -12.79% | 6.37% | 46.05% | 17.85% | 72.59% |
| Book Value per Share | 16.19 | 17.11 | 17.07 | 14.07 | 15.03 | 12.99 | 13.26 | 19.13 | 22.24 | 24.31 |
| Total Shareholders' Equity | 43.76M | 47.06M | 47.1M | 38.41M | 41.24M | 35.69M | 37.41M | 54.76M | 64.46M | 70.67M |
| Common Stock | 6.79M | 6.84M | 6.88M | 6.88M | 6.92M | 6.98M | 7.08M | 7.27M | 7.35M | 7.42M |
| Retained Earnings | 39.77M | 43.16M | 43.55M | 37.82M | 34.15M | 28.02M | 28.76M | 47.51M | 58.92M | 65.15M |
| Treasury Stock | -53K | -53K | -53K | -53K | -53K | -53K | -53K | -2.05M | -3.65M | 0 |
| Accumulated OCI | -6.32M | -5.9M | -6.41M | -9.6M | -3.58M | -3.74M | -3.44M | -3.38M | -3.8M | -4.77M |
| Minority Interest | 374K | 462K | 603K | 288K | 246K | 486K | 1.08M | 1.45M | 1.79M | 1.85M |
KEQU Cash Flow Statement
Kewaunee Scientific Corporation (KEQU) cash flow — operating, investing & free cash flow history
| Line item | Apr'17 | Apr'18 | Apr'19 | Apr'20 | Apr'21 | Apr'22 | Apr'23 | Apr'24 | Apr'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 11.66M | 3.18M | 2.49M | 4.16M | 912K | -7.88M | -3.79M | 19.56M | 14.78M | 14.78M |
| Operating CF Margin % | 8.42% | 2.01% | 1.7% | 2.82% | 0.62% | -4.67% | -1.73% | 9.6% | 6.15% | - |
| Operating CF Growth % | 60.39% | -72.71% | -21.77% | 67.11% | -78.08% | -964.58% | 51.93% | 616.2% | -24.44% | 2014.35% |
| Net Income | 4.62M | 5.37M | 1.69M | -4.62M | -3.61M | -6M | 1.36M | 18.75M | 11.58M | 11.08M |
| Depreciation & Amortization | 2.7M | 2.76M | 2.57M | 2.65M | 2.69M | 2.77M | 2.87M | 3.13M | 4.76M | 6.3M |
| Stock-Based Compensation | 199K | 355K | 197K | 251K | 634K | 729K | 886K | 1.03M | 1.44M | 1.99M |
| Deferred Taxes | 234K | 1.13M | 202K | 1.9M | 1.66M | 120K | 516K | -7.13M | -2.2M | 9K |
| Other Non-Cash Items | 37K | 344K | 65K | 364K | 53K | 92K | 120K | 580K | 1.22M | 459K |
| Working Capital Changes | 3.87M | -6.77M | -2.23M | 3.62M | -517K | -5.59M | -9.54M | 3.21M | -2.02M | 2.1M |
| Change in Receivables | -2.09M | -3.12M | -664K | 4.83M | -6.09M | -8.46M | -4.95M | 741K | -6.74M | 3.29M |
| Change in Inventory | 691K | -2.73M | 456K | 1.88M | -1.19M | -7.28M | 1.91M | 1.21M | 3.35M | 431K |
| Change in Payables | 686K | 4.56M | -55K | -2.02M | 6.33M | 11.89M | -5.56M | 0 | 0 | 78K |
| Cash from Investing | -2.48M | -3.2M | -4.21M | -2.46M | -2.4M | -1.91M | -4.15M | -4.37M | -30.9M | -3.52M |
| Capital Expenditures | -2.61M | -3.4M | -4.21M | -2.46M | -2.4M | -1.91M | -4.15M | -4.37M | -2.17M | -3.52M |
| CapEx % of Revenue | 1.88% | 2.15% | 2.87% | 1.67% | 1.63% | 1.13% | 1.89% | 2.15% | 0.9% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28.73M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 132K | 193K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -2.08M | -2.48M | 2.33M | -7.46M | 1.98M | 11.03M | 14.93M | -3.01M | 7.41M | -20.71M |
| Debt Issued (Net) | -648K | -624K | 4.45M | -6.08M | 2.09M | 11.03M | 15.51M | -528K | 10.77M | -2.79M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K |
| Dividends Paid | -1.57M | -1.79M | -2.03M | -1.04M | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 36K | 0 | 0 | 0 | 0 | -2M | -1.6M | -1.6M |
| Other Financing | 134K | -66K | -87K | -338K | -108K | 0 | -575K | -488K | -1.76M | -16.33M |
| Net Change in Cash | 7.28M▲ 0% | -2.79M▼ 138.3% | 198K▲ 107.1% | -5.94M▼ 3100.5% | 516K▲ 108.7% | 1.16M▲ 125.4% | 6.92M▲ 495.1% | 12.12M▲ 75.2% | -8.77M▼ 172.4% | -1.99M▲ 0% |
| Free Cash Flow | 9.05M▲ 0% | -212K▼ 102.3% | -1.72M▼ 712.7% | 1.7M▲ 198.4% | -1.49M▼ 187.6% | -9.79M▼ 559.5% | -7.94M▲ 18.9% | 15.19M▲ 291.4% | 12.62M▼ 16.9% | 19.05M▲ 0% |
| FCF Margin % | 6.53% | -0.13% | -1.18% | 1.15% | -1.01% | -5.8% | -3.62% | 7.46% | 5.25% | 6.62% |
| FCF Growth % | 78.03% | -102.34% | -712.74% | 198.43% | -187.56% | -559.46% | 18.94% | 291.37% | -16.94% | 389.59% |
| FCF per Share | 3.32 | -0.08 | -0.62 | 0.62 | -0.54 | -3.52 | -2.74 | 5.17 | 4.24 | 4.24 |
| FCF Conversion (FCF/Net Income) | 2.58x | 0.61x | 1.63x | -0.90x | -0.25x | 1.31x | -2.79x | 1.04x | 1.30x | 1.72x |
| Interest Paid | 292K | 295K | 352K | 513K | 0 | 480K | 1.86M | 1.8M | 3.37M | 1.84M |
| Taxes Paid | 2.62M | 2.87M | 2.46M | 188K | 0 | 1.01M | 3.16M | 6.24M | 3.97M | 0 |
KEQU Key Ratios
Kewaunee Scientific Corporation (KEQU) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 10.92% | 11.32% | 3.21% | -10.7% | -9% | -15.46% | 3.64% | 39.61% | 18.63% | 15.86% |
| Return on Invested Capital (ROIC) | 13.31% | 17.25% | 3.49% | -3.66% | -1.96% | -2.58% | 3.82% | 31.42% | 18.32% | 18.32% |
| Gross Margin | 19.2% | 20.26% | 17.28% | 15.88% | 16.27% | 14.34% | 16.21% | 25.55% | 28.63% | 28.93% |
| Net Margin | 3.26% | 3.28% | 1.04% | -3.13% | -2.45% | -3.55% | 0.62% | 9.2% | 4.74% | 3.85% |
| Debt / Equity | 0.10x | 0.11x | 0.23x | 0.36x | 0.39x | 1.87x | 0.34x | 0.20x | 0.76x | 0.76x |
| Interest Coverage | 22.40x | 30.39x | 5.75x | -4.76x | -3.38x | -4.13x | 2.09x | 10.16x | 5.53x | 4.64x |
| FCF Conversion | 2.58x | 0.61x | 1.63x | -0.90x | -0.25x | 1.31x | -2.79x | 1.04x | 1.30x | 1.72x |
| Revenue Growth | 7.72% | 14.07% | -7.28% | 0.68% | -0.05% | 14.51% | 29.98% | -7.17% | 18.02% | 30.78% |
KEQU Frequently Asked Questions
Kewaunee Scientific Corporation (KEQU) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Kewaunee Scientific Corporation (KEQU) reported $287.7M in revenue for fiscal year 2025. This represents a 400% increase from $57.6M in 1996.
Kewaunee Scientific Corporation (KEQU) grew revenue by 18.0% over the past year. This is strong growth.
Yes, Kewaunee Scientific Corporation (KEQU) is profitable, generating $11.1M in net income for fiscal year 2025 (4.7% net margin).
Dividend & Returns
Kewaunee Scientific Corporation (KEQU) has a return on equity (ROE) of 18.6%. This is reasonable for most industries.
Kewaunee Scientific Corporation (KEQU) generated $19.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More KEQU
Kewaunee Scientific Corporation (KEQU) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates